Pfizer

The global psychedelic drugs market is set for rapid expansion, with projections forecasting growth from $4.88 billion in 2023 to $10.2 billion by 2028, according to The Business Research Company. With a compound annual growth rate of 16.1%, this rise is largely driven by increased awareness of...

On Thursday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Moderna Inc (NASDAQ:MRNA). This decision comes amidst a backdrop of mixed analyst sentiments and Moderna’s recently unveiled post-COVID roadmap. The Moderna Trade Ark Invest’s ARK Genomic Revolution...

The global psychedelic drugs market is poised for significant growth over the next five years, with an estimated increase of USD 1.37 billion from 2024 to 2028, according to a report by Technavio. The market is projected to grow at a compound annual growth rate (CAGR) of 11.82%, fueled by the...

Pfizer Inc. (NYSE:PFE) has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5 billion by the end of 2027. What Happened: The new program builds on a $4 billion cost reduction plan announced last year, Reuters reported on Thursday. This move comes as the company faces...

An 18-month-old British child has regained her hearing through a pioneering gene therapy, marking a significant stride in the treatment of deafness. What Happened: Opal Sandy, who was born with a rare genetic condition that left her completely deaf, has now been able to hear without the need for...

Wednesday saw a mixed performance in major U.S. indices. The Dow Jones Industrial Average closed the day with a 0.2% increase at 37,903.29, while the S&P 500 finished lower by 0.3% at 5,018.39. Similarly, the Nasdaq ended the day down 0.33% at 15,605.48. These are the top stocks that gained the...

The Centers for Disease Control and Prevention (CDC) has recommended a second annual COVID-19 vaccine for individuals aged 65 and above. This decision comes in the wake of a significant increase in COVID-19 hospitalizations among older Americans. What Happened: The CDC’s Advisory Committee...

Pfizer Inc (NYSE:PFE) has agreed to pay $93 million to settle an antitrust lawsuit related to its cholesterol drug Lipitor. What Happened: The lawsuit, filed by wholesale drug distributors, accused Pfizer of colluding with India’s Ranbaxy Laboratories to delay the sale of cheaper, generic...

The stock market witnessed a notable surge today, with the Dow Jones rising 0.43% to 37,248.35 and the S&P 500 gaining 0.26% to 4,719.55. The Nasdaq also ended Thursday in the green appreciating 0.19% to 14,761.56. Transitioning from the broader market, we now turn our focus to individual...

Major U.S. indices were in the green on Wednesday with the Dow Jones rising 1.4% to 37,090.24, the S&P 500 gaining 1.37% to 4,707.09 and the tech-heavy Nasdaq appreciating 1.38% to 14,733.96. On the same day, Federal Reserve Chair Jerome Powell signaled a peak in interest rates and foresaw cuts...

According to an Associated Press report, the Israel-Hamas conflict has stirred up controversy within the global business sector. High-ranking executives and ordinary workers alike are grappling with the repercussions of voicing their opinions on the issue. The CEO of Pfizer Inc., Albert Bourla...

U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday. The tech-heavy index closed at 13,917.89 for the day. The Dow Jones Industrial Average also reflected an upward trend, increasing by 0.25%...

U.S. stocks experienced a downward trend midway through trading, with the Dow Jones declining approximately 200 points on Wednesday. The Dow ended Wednesday lower by 0.57% to 34,443.19, while the NASDAQ saw a decrease of 1.06% to 13,872.47. Similarly, the S&P 500 also witnessed a drop, falling...

Recent research conducted by Viridian Capital Advisors reveals that the cannabis sector requires more capital as compared to other similar industries. The findings offer a unique perspective into the challenges the cannabis industry faces, especially considering the potential for federal...

On Tuesday, the European Union’s drug regulator expanded its investigation into the risk of suicidal thoughts and self-injury among patients taking weight loss and diabetes medications, including those produced by Novo Nordisk (NASDAQ:NVO). The probe now encompasses about 150 reported cases...